GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Posts Tagged ‘NASDAQ:SRPT’
Johnson & Johnson (JNJ), Sarepta Therapeutics Inc (SRPT), Edwards Lifesciences Corp (EW): 3 Health Care Investment Ideas for June
If you heeded the old adage to "sell in May and go away" this year, you're probably second-guessing your decision now.
Santarus, Inc. (SNTS): Insiders Are Buying, Should You?
If you'd ask most shareholders, hedge funds are assumed to be underperforming, old investment tools of the past.
This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds' portfolio at the end of March.
Aegerion Pharmaceuticals, Inc. (AEGR): A $90 Price Target for This Biotech! How’s It Figured?
Aegerion Pharmaceuticals, Inc.
Liberty Media Corp (LMCA), Sarepta Therapeutics Inc (SRPT): Here’s What This $42 Billion Hedge Fund Company Has Been Buying
Shaw is known as a math wizard, and a quantitative investing pioneer. His firm is reportedly extremely selective, hiring less than 1% of applicants -- and Amazon.com, Inc.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Where to Invest for More Health-Care Exposure
You have plenty of choices of where to invest your portfolio.
MeadWestvaco Corp. (MWV), Brocade Communications Systems, Inc. (BRCD): What George Soros Has Been Buying
George Soros is known to some folks these days for his politics and philanthropy, but his fame stems from his wealth, which is a result of his outstanding investing prowess.
Keryx Biopharmaceuticals (KERX), Dynavax Technologies Corporation (DVAX): Biotech Investing for Beginners
Huge fortunes are won and lost in the world of biotech nearly every week. For those new to this world, it can appear both alluring and scary.
Sarepta Therapeutics Inc (SRPT): Sad Trombone?
The words of the great big-band leader Duke Ellington came to mind after hearing the first quarter results from Sarepta Therapeutics Inc (NASDAQ:SRPT) : "It don't mean a thing...
Questcor Pharmaceuticals Inc (QCOR): Impressive Revenue Growth
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) has faced the affects of bad press more than once in the past.
Edwards Lifesciences Corp (EW), Sarepta Therapeutics Inc (SRPT), Rigel Pharmaceuticals, Inc. (RIGL): April’s Unhealthiest Stocks
Leading health-care stocks have had a good start to the year, but all's not healthy in the world of medicine.
Sarepta Therapeutics Inc (SRPT), Pharmacyclics, Inc. (PCYC): Are These Billion-Dollar Biotechs Overvalued?
Biotechs with market caps of a billion dollars or more are a dime a dozen. Well, actually, they're more like $12 billion or more a dozen, but you get the point.
Vertex Pharmaceuticals Incorporated (VRTX), MannKind Corporation (MNKD): Want to Invest in Biotech? Think Like a Venture Capitalist
They're demanding. They take risks -- but only calculated ones. And they ask lots of penetrating questions to understand as much as possible before putting a dime on the line.
Nokia Corporation (ADR) (NOK), Freeport-McMoRan Copper & Gold Inc. (FCX) & Five of Last Week’s Biggest Losers
Let's start with Magnum Hunter Resources. Investors bailed on Magnum Hunter after the oil and gas explorer bailed on its auditor.
Allergan, Inc. (AGN), Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK) & The Week, Biotech
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Sarepta Therapeutics Inc (SRPT): FDA Says, “Call Me Maybe”
A lot has been written this week -- at The Fool and elsewhere -- about Sarepta Therapeutics Inc (NASDAQ:SRPT)' update on its meeting with the Food and Drug Administration.
GlaxoSmithKline plc (ADR) (GSK), Sarepta Therapeutics Inc (SRPT): Telecoms Disconnected as These Two Stocks Tumbled
So much for the big correction.
Sarepta Therapeutics Inc (SRPT): Why This Stock’s Shares Fell
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Sarepta Therapeutics Inc (SRPT): Two Viewpoints On The FDA News
Sarepta Therapeutics Inc (NASDAQ:SRPT) announced yesterday after the market closed that the U.S.
Sarepta Therapeutics Inc (SRPT) Is A Gamble Worth Taking
There is always something interesting happening in the Bio-Pharma sector due to a number of firms working on several new drugs.
Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of the fourth quarter of 2012.
Whoa…First Solar, Inc. (FSLR), Microsoft Corporation (MSFT), Intel Corporation (INTC): What Just Happened to My Stock?
The Dow Jones Industrial Average (Dow Jones Indices:.DJI) flashed a 60-point gain yesterday driven higher by the tech sector and its old dynamic duo, Microsoft Corporation (NASDAQ...
Alexion Pharmaceuticals, Inc. (ALXN), Align Technology, Inc. (ALGN) & More: Three Surprising Investment Ideas Straight From Obamacare
You can find investment ideas in the strangest places. Take Obamacare, for example.
Sarepta Therapeutics Inc (SRPT), Keryx Biopharmaceuticals (KERX), MannKind Corporation (MNKD): Three Speculative Biotech Companies Primed to Pop
They don't have any products on the market. They have little or no revenue. Earnings? Nada. Many people are betting that they will fail.
This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT): Acorda Therapeutics Inc (ACOR), Nektar Therapeutics (NKTR)
According to most traders, hedge funds are perceived as underperforming, old investment tools of yesteryear.
Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG): Is This the Next Investing Bubble?
With the Nasdaq Biotechnology Index hitting record highs, Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to chat about whether we're in...
Antares Pharma Inc (ATRS), ARMOUR Residential REIT, Inc. (ARR): 5 Fast Growers for Your Consideration
When building your portfolio, aim for diversification. You should aim to hold both large and small companies (plus mid-sized ones) and companies in a range of industries.
3 Earnings Reports That Caught My Attention Last Week: Ciena Corporation (CIEN), Smith & Wesson Holding Corporation (SWHC)
As first-quarter earnings begin to wind down, I can't help but point out that the majority of earnings reports we've covered over the past year have been better than expected.
What You Need to Know About Sarepta Therapeutics Inc (SRPT)’s Q4 Update
Sarepta Therapeutics Inc (NASDAQ:SRPT) was on fire in 2012, landing at the top of the list of The Motley Fool's best health-care stocks of the year.
Can’t-Miss Health-Care Events This Week: GlaxoSmithKline plc (ADR)(GSK), Theravance Inc (THRX)
On Monday, Depomed Inc (NASDAQ:DEPO) is expected to go before the FDA panel with its menopausal hot-flash drug, Serada.
Here’s What George Soros Has Been Buying and Selling: RF Micro Devices, Inc. (RFMD) and More
George Soros is known to some folks these days for his politics and philanthropy, but his fame stems from his wealth, which is a result of his outstanding investing prowess.
BioMarin Pharmaceutical Inc. (BMRN) is a Prime Takeover Target
How many of us as investors want to identify companies that are pioneers in their industry? Is it possible to find commonality across sectors, which factors make specific companies...
StemCells, Inc. (STEM) Have a Long Way to Go: Sarepta Therapeutics Inc (SRPT)
StemCells, Inc. (NASDAQ:STEM) stock jumped more than 20% after the biotech released long-term data for its neural stem cell product HuCNS-SC, but investors seem to be coming ...
What’s Next for Sarepta Therapeutics Inc (SRPT)?
What's next for Sarepta Therapeutics Inc (NASDAQ:SRPT) ? After announcing encouraging results last October from a phase 2b study of eteplirsen targeting treatment of Duchenne...
Two Small-Cap Stocks to Trade Considerably Higher in February: XPO Logistics Inc (XPO), Sarepta Therapeutics Inc (SRPT)
There is something exciting about a small cap stock.
Here’s What Tocqueville Asset Management Has Been Buying and Selling: Sarepta Therapeutics Inc (SRPT), Amarin Corporation plc (AMRN)
Today, let's look at Tocqueville Asset Management, which is a portfolio manager with a contrarian bent, believing that "the best investment results over time are achieved outside...
